HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supplement GMPs Planned For September In “Unified Agenda”

This article was originally published in The Tan Sheet

Executive Summary

FDA has slated September as the release date for the long-awaited dietary supplement current good manufacturing practices final rule, according to HHS' semi-annual "unified agenda" published May 16 in the Federal Register

You may also be interested in...

Nonoxynol-9 Messages Conveyed By HHS Agencies Inconsistent – GAO Report

FDA will release three documents this year on the use of spermicidal lubricant nonoxynol-9 in condoms and vaginal contraceptives to protect against HIV transmission

“Solid” GMPs Will Give FDA Adequate Supplement Enforcement – Crawford

FDA will have the necessary tools to effectively regulate dietary supplements once it implements the pending Good Manufacturing Practices final rule, acting Commissioner Lester Crawford states

Sinusitis Exclusion From Nasal Decongestant Labels Is Unsupported – Pfizer

Physician intervention could be the only recourse for consumers suffering from sinusitis if FDA were to remove the indication from OTC product labels, according to Pfizer Consumer Healthcare

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts